APA (7th ed.) Citation

M, S., M, M., A, A., R, F., P, S., R, S., . . . S, C. (2026). Evaluation of a combination of off-label PDE5 inhibitor and tamoxifen in acute Peyronie's disease. The journal of sexual medicine, 23(6), . https://doi.org/10.1093/jsxmed/qdag120

Chicago Style (17th ed.) Citation

M, Shah, et al. "Evaluation of a Combination of Off-label PDE5 Inhibitor and Tamoxifen in Acute Peyronie's Disease." The Journal of Sexual Medicine 23, no. 6 (2026). https://doi.org/10.1093/jsxmed/qdag120.

MLA (9th ed.) Citation

M, Shah, et al. "Evaluation of a Combination of Off-label PDE5 Inhibitor and Tamoxifen in Acute Peyronie's Disease." The Journal of Sexual Medicine, vol. 23, no. 6, 2026, https://doi.org/10.1093/jsxmed/qdag120.